These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26400455)

  • 1. Improving metabolic monitoring in patients maintained on antipsychotics in Penang, Malaysia.
    Hor ES; Subramaniam S; Koay JM; Bharathy A; Vasudevan U; Panickulam JJ; Ng I; Arif NH; Russell V
    Australas Psychiatry; 2016 Feb; 24(1):67-71. PubMed ID: 26400455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of a point-of-care metabolic risk screening program in outpatients receiving antipsychotic agents.
    Schneiderhan ME; Batscha CL; Rosen C
    Pharmacotherapy; 2009 Aug; 29(8):975-87. PubMed ID: 19637951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for the metabolic syndrome in Australia: a national survey of psychiatrists' attitudes and reported practice in patients prescribed antipsychotic drugs.
    Laugharne J; Waterreus AJ; Castle DJ; Dragovic M
    Australas Psychiatry; 2016 Feb; 24(1):62-6. PubMed ID: 26635377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
    Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
    Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome and antipsychotic monotherapy treatment among schizophrenia patients in Malaysia.
    Said MA; Hatim A; Habil MH; Zafidah W; Haslina MY; Badiah Y; Ramli MA; Ananjit S; Sapini Y; Shah M; Mahmud B; Bulgiba A; Hairi NN
    Prev Med; 2013; 57 Suppl():S50-3. PubMed ID: 23337566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse-assessed metabolic monitoring: a file audit of risk factor prevalence and impact of an intervention to enhance measurement of waist circumference.
    Rosenbaum S; Nijjar S; Watkins A; Garwood N; Sherrington C; Tiedemann A
    Int J Ment Health Nurs; 2014 Jun; 23(3):252-6. PubMed ID: 24393271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effective screening for the metabolic syndrome in patients treated with second-generation antipsychotic medications.
    Straker D; Correll CU; Kramer-Ginsberg E; Abdulhamid N; Koshy F; Rubens E; Saint-Vil R; Kane JM; Manu P
    Am J Psychiatry; 2005 Jun; 162(6):1217-21. PubMed ID: 15930076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The metabolic syndrome and its constituting variables in atypical antipsychotic-treated subjects: comparison with other drug treatments, drug-free psychiatric patients, first-degree relatives and the general population in Venezuela.
    Baptista T; Serrano A; Uzcátegui E; ElFakih Y; Rangel N; Carrizo E; Fernández V; Connell L; de Baptista EA; Quiroz S; Uzcátegui M; Rondón J; Matos Y; Uzcátegui L; Gómez R; Valery L; Novoa-Montero D
    Schizophr Res; 2011 Mar; 126(1-3):93-102. PubMed ID: 21071179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications.
    Hasnain M; Vieweg WV; Fredrickson SK; Beatty-Brooks M; Fernandez A; Pandurangi AK
    Prim Care Diabetes; 2009 Feb; 3(1):5-15. PubMed ID: 19083283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can We Improve Physical Health Monitoring for Patients Taking Antipsychotics on a Mental Health Inpatient Unit?
    Ross E; Barnett R; Tudhope R; Vasudev K
    J Clin Psychopharmacol; 2018 Oct; 38(5):447-453. PubMed ID: 30113352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme.
    Barnes TR; Paton C; Hancock E; Cavanagh MR; Taylor D; Lelliott P;
    Acta Psychiatr Scand; 2008 Jul; 118(1):26-33. PubMed ID: 18582345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Explicit review of risperidone long-acting injection prescribing practice.
    Wheeler A; Vanderpyl J; Carswell C; Stojkovic M; Robinson E
    J Clin Pharm Ther; 2011 Dec; 36(6):651-63. PubMed ID: 22023342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic risk status and second-generation antipsychotic drug selection: a retrospective study of commercially insured patients.
    Morrato EH; Cuffel B; Newcomer JW; Lombardo I; Kamat S; Barron J
    J Clin Psychopharmacol; 2009 Feb; 29(1):26-32. PubMed ID: 19142103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a computer-based intervention to enhance metabolic monitoring in psychiatry inpatients treated with second-generation antipsychotics.
    DelMonte MT; Bostwick JR; Bess JD; Dalack GW
    J Clin Pharm Ther; 2012 Dec; 37(6):668-73. PubMed ID: 22845616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Audit of antipsychotic prescribing in dementia: Cambridgeshire results and lessons learnt.
    Wightman R; Fielding J; Green S
    Psychiatr Danub; 2011 Sep; 23 Suppl 1():S126-9. PubMed ID: 21894119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical health of patients with severe mental illness: an intervention on medium secure forensic unit.
    Vasudev K; Thakkar PB; Mitcheson N
    Int J Health Care Qual Assur; 2012; 25(4):363-70. PubMed ID: 22755485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The discriminative ability of waist circumference, body mass index and waist-to-hip ratio in identifying metabolic syndrome: Variations by age, sex and race.
    Cheong KC; Ghazali SM; Hock LK; Subenthiran S; Huey TC; Kuay LK; Mustapha FI; Yusoff AF; Mustafa AN
    Diabetes Metab Syndr; 2015; 9(2):74-8. PubMed ID: 25819369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for Metabolic Syndrome in Mental Health Consumers Using an Electronic Metabolic Monitoring Form.
    Stanton R; Platania-Phung C; Gaskin CJ; Happell B
    Issues Ment Health Nurs; 2016; 37(4):239-44. PubMed ID: 26963890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of patients' preexisting metabolic risk factors on the choice of antipsychotics by office-based physicians.
    Li C; Mittal D; Owen RR
    Psychiatr Serv; 2011 Dec; 62(12):1477-84. PubMed ID: 22193796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.